go-v.orgdoi

Safety of Metformin Continuation During Peri-Procedural Period of Coronary Angiography in Type 2 Diabetic Patients

Dana Hama-Baqi Mohammed-Saeed · Advanced medical journal · 2025

  • DOI 10.56056/403
  • Publisher Kurdistan Higher Council of Medical Specialties
  • Type article
  • Issued 2025

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Advanced medical journal · Kurdistan Higher Council of Medical Specialties · article · 2025

Abstract

Background The safety of maintaining metformin therapy in patients undergoing coronary angiography is a topic of ongoing debate. The present study aims to examine patients with type 2 diabetes who continued to use metformin while undergoing coronary angiography for the development of contrast-induced nephropathy and lactic acidosis. Patients and Methods This investigation was a cross-sectional study that was carried out in Sulaimani Cardiac Hospital between January 2023 to June 2023 that enrolled 100 patients with type 2 diabetes and baseline creatinine clearance more than 45 ml/min for whom elective coronary angiography was performed.

Monitoring of renal function and clinical signs of lactic acidosis were observed. Results The majority of cases (57%) received less than 50 cc of contrast, followed by 50-150 cc in 32 cases. Only one patient, a 70-year-old woman with a baseline impaired creatinine level (1.4 mg/dL), developed contrast-induced nephropathy, and there was no statistically significant change in creatinine level. With vigilant monitoring and proper hydration, her renal function returned to baseline levels within 7 days after the angiogram. Furthermore, there was no lactic acidosis in any of the participants.

Conclusion It appears to be safe to continue metformin therapy during coronary angiography for type 2 diabetic patients whose baseline creatinine clearance above 45 ml/min.

Open the resolved locator · 10.56056/403

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 14:33 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.56056/403
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.